Literature DB >> 30557129

Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study.

Sandra Haider1, Igor Grabovac2, Carolin Berner3, Thomas Lamprecht4, Karl-Heinrich Fenzl4, Ludwig Erlacher5, Michael Quittan6, Thomas E Dorner1.   

Abstract

OBJECTIVES: The prevalence of frailty has been widely researched in the elderly population. However, data about people of working age are scarce. The aim of this paper was to assess the prevalence of prefrailty and frailty in rheumatoid arthritis (RA) patients of working age, and to assess factors associated with prefrailty/frailty.
METHODS: In this monocentric cross-sectional study, 100 RA patients aged 18-65 years were included. Frailty was measured with the Frailty Instrument for Primary Care of the Survey of Health, Ageing and Retirement in Europe (SHARE-FI) and disease activity with the Clinical Disease Activity Index (CDAI). In addition, disease duration (years), pain intensity (visual analogue scale) and employment status were also assessed.
RESULTS: Fifty-five percent were robust, 30% prefrail and 15% were frail. Eighty-nine of the prefrail/frail individuals suffered from exhaustion. Compared to robust individuals, the prefrail/frail individuals had significantly higher median scores in disease activity [4.0 (Q25-Q75: 0-10) vs. 11 (Q25-Q75: 6-18)] and pain intensity [3.0 (Q25-Q75: 2.0-4.0) vs. 4.0 (Q25-Q75: 2.8-6.3)] and a higher rate of unemployment [31% vs. 53%]. In the multivariable analysis, higher disease activity (ß=0.444; p<0.001), unemployment (ß=0.243; p=0.005), higher pain intensity (ß=0.186; p=0.060) and longer disease duration (ß=0.181; p=0.020) were associated with a higher frailty score.
CONCLUSIONS: Frailty is common in RA patients, even those of working age. As the prevalence of frailty increases with age, it is important to take this syndrome into account in younger persons and to take action to counteract frailty.

Entities:  

Mesh:

Year:  2018        PMID: 30557129

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Suppression of trimethylamine N-oxide with DMB mitigates vascular dysfunction, exercise intolerance, and frailty associated with a Western-style diet in mice.

Authors:  Vienna E Brunt; Nathan T Greenberg; Zachary J Sapinsley; Abigail G Casso; James J Richey; Nicholas S VanDongen; Rachel A Gioscia-Ryan; Brian P Ziemba; Andrew P Neilson; Kevin P Davy; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2022-08-11

Review 2.  Inflammaging and Frailty in Immune-Mediated Rheumatic Diseases: How to Address and Score the Issue.

Authors:  Fausto Salaffi; Andrea Di Matteo; Sonia Farah; Marco Di Carlo
Journal:  Clin Rev Allergy Immunol       Date:  2022-05-21       Impact factor: 10.817

3.  Sex differences in frailty and its association with low bone mineral density in rheumatoid arthritis.

Authors:  Katherine D Wysham; Dolores M Shoback; James S Andrews; Patricia P Katz
Journal:  Bone Rep       Date:  2020-05-22

4.  Frailty in rheumatoidrmdopen-2021-002111 arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank.

Authors:  Peter Hanlon; Fraser Morton; Stefan Siebert; Bhautesh D Jani; Barbara I Nicholl; Jim Lewsey; David McAllister; Frances S Mair
Journal:  RMD Open       Date:  2022-03

5.  Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset.

Authors:  Sarah B Lieber; Iris Navarro-Millán; Mangala Rajan; Jeffrey R Curtis; Sebastian E Sattui; Geyanne Lui; Sergio Schwartzman; Lisa A Mandl
Journal:  ACR Open Rheumatol       Date:  2022-01-05

6.  Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.

Authors:  Bharati D Kochar; Winston Cai; Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2021-05-01       Impact factor: 3.199

Review 7.  Frailty in Rheumatic Diseases.

Authors:  Francesca Motta; Antonio Sica; Carlo Selmi
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

8.  Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis.

Authors:  Fausto Salaffi; Rossella De Angelis; Sonia Farah; Marina Carotti; Marco Di Carlo
Journal:  Clin Rheumatol       Date:  2021-07-20       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.